Drugs Controller General of India (DCGI) has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate...
from NDTV News - Special https://ift.tt/2Fksy5W
https://ift.tt/eA8V8J https://www.ndtv.com
from NDTV News - Special https://ift.tt/2Fksy5W
https://ift.tt/eA8V8J https://www.ndtv.com
Post a Comment